Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation | NEJM
Dalla non inferiorita alla superiorita i NAO sono
New Insights into Post-PCI Care: The RE-DUAL PCI Study | Oruen-Cardiology
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions
RE-DUAL PCI: dual antithrombotic therapy with dabigatran after percutaneous coronary intervention in patients with atrial fibrillation | Challenges in Cardiology
Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI - ScienceDirect
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation | NEJM
AF and PCI in Practice. - ppt download
RE-DUAL PCI Trial: Inclusion and Main Exclusion Criteria and Study Design | ECR Journal
4 dan atar - anticoagulation af pci - what do trials say
REC: Interventional Cardiology - Special article
RE-DUAL OAC switching subanalysis animated video | boehringerone.com
RE-DUAL PCI: dual antithrombotic therapy with dabigatran after percutaneous coronary intervention in patients with atrial fibrillation | Challenges in Cardiology
Key sub-analyses of RE-DUAL PCI™ showed large reductions in the incidence of bleeding complications if Pradaxa® (dabigatran etexilate) dual therapy was used instead of warfarin triple therapy | Business Wire
PCRonline - The RE-DUAL PCI trial subanalysis: In spite of... | Facebook
The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status | tctmd.com
Khaleej Dailies: Pradaxa® (dabigatran etexilate) dual therapy showed lower rates of major bleeding versus triple therapy with warfarin in atrial fibrillation patients undergoing stent placement
Design and Rationale of the RE‐DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients
Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? | Semantic Scholar
REDUAL PCI dual antithrombotic therapy with dabigatran after
redual - Twitter Search / Twitter
Ph.Gabriel Steg on Twitter: "Dabigatran-based dual therapy compared to triple therapy with warfarin in patients with AFib and PCI in REDUAL PCI : Interaction between age and dabigatran dose https://t.co/YjILU5SrVb @cpcannon @
Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? | Request PDF
